Jim Cramer Calls Tandem Diabetes "Speculative Stock for Younger People"

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) is one of the stocks Jim Cramer shared insights on. Inquiring about the stock during the lightning round, a caller expressed that their son and grandson use products made by the company. Here’s what Cramer had to say in response:

“Alright, so… this is one of those, this is really difficult because I want to go with them, and the reason I want to go with them is they’re young. If they made a mistake, they got their whole life ahead of them. They’ve had the personal use of it. I looked at the company and said, jeez, I don’t like the fact that they keep losing money, but you know what? Let’s go with them and see what happens. Speculative stock for younger people, I actually encourage.”

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) develops insulin delivery systems and digital health tools, infusion sets, cartridges, and platforms to support diabetes management.

While we acknowledge the potential of TNDM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.